Stevanato Group (NYSE:STVN) Stock Price Up 1.7% – Time to Buy?

Stevanato Group S.p.A. (NYSE:STVN) shot up 1.7% during trading on Thursday . The company traded as high as €22.34 ($23.52) and last traded at €22.14 ($23.31). 44,183 shares were traded during trading, a decline of 91% from the average session volume of 499,598 shares. The stock had previously closed at €21.76 ($22.91).

Analyst Ratings Changes

STVN has been the topic of a number of recent analyst reports. Bank of America lifted their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Wolfe Research began coverage on shares of Stevanato Group in a research report on Friday. They set an “outperform” rating and a $28.00 target price for the company. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of €28.60 ($30.11).

Stevanato Group Price Performance

The firm has a 50-day moving average price of €19.67 and a two-hundred day moving average price of €19.67. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. Stevanato Group’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the company earned $0.16 earnings per share. As a group, sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 EPS for the current year.

Institutional Trading of Stevanato Group

A number of hedge funds have recently modified their holdings of the company. Thrivent Financial for Lutherans bought a new position in shares of Stevanato Group during the 2nd quarter worth about $30,477,000. Pembroke Management LTD boosted its holdings in Stevanato Group by 143.7% during the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after purchasing an additional 619,747 shares in the last quarter. Tri Locum Partners LP acquired a new stake in Stevanato Group during the second quarter valued at approximately $10,370,000. Thornburg Investment Management Inc. grew its stake in shares of Stevanato Group by 279.1% in the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock valued at $13,690,000 after purchasing an additional 549,378 shares during the period. Finally, Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 7.3% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock worth $133,439,000 after buying an additional 496,930 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.